Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis Type 2”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131722
What this trial is testing

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

Who this might be right for
Neurofibromatosis Type IINF2
PRG Science & Technology Co., Ltd. 25
Testing effectiveness (Phase 2)Looking for participantsNCT02523014
What this trial is testing

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Who this might be right for
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology 124
Very early researchStudy completedNCT01880749
What this trial is testing

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomasMeningiomas
NYU Langone Health 5
Not applicableStudy completedNCT01904448
What this trial is testing

Auditory Brainstem Implantation in Young Children

Who this might be right for
Developmental Cochlear Nerve DeficiencyAcquired Cochlear Nerve DeficiencyCochlear Aplasia+2 more
University of North Carolina, Chapel Hill 5
Testing effectiveness (Phase 2)Study completedNCT01490476
What this trial is testing

Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients

Who this might be right for
Neurofibromatosis 2
Assistance Publique - Hôpitaux de Paris 10
Not applicableStudy completedNCT03406208
What this trial is testing

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Who this might be right for
NeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2+1 more
Massachusetts General Hospital 228
Not applicableNot Yet RecruitingNCT06834438
What this trial is testing

Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002

Who this might be right for
NF2 Deficiency
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07708285
What this trial is testing

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

Who this might be right for
NF2-related SchwannomatosisNF2Neurofibromatosis Type 2+2 more
Beijing Tiantan Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT04166409
What this trial is testing

The Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Who this might be right for
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade Astrocytoma+3 more
National Cancer Institute (NCI) 170
Testing effectiveness (Phase 2)Study completedNCT02934256
What this trial is testing

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Li Peng 10
Not applicableLooking for participantsNCT00598351
What this trial is testing

Natural History Study of Patients With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis
National Institute of Neurological Disorders and Stroke (NINDS) 269
Not applicableStudy completedNCT04879160
What this trial is testing

Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Testing effectiveness (Phase 2)Study completedNCT04283669
What this trial is testing

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis 2Progressive Vestibular Schwannoma (VS)
University of Alabama at Birmingham 12
Not applicableStudy completedNCT02435628
What this trial is testing

Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF

Who this might be right for
Neurofibromatosis
Massachusetts General Hospital 86
Testing effectiveness (Phase 2)Study completedNCT00004437
What this trial is testing

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Who this might be right for
Neurofibromatosis 2
FDA Office of Orphan Products Development
Testing effectiveness (Phase 2)Study completedNCT00589784
What this trial is testing

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Who this might be right for
CNS CancerMeningiomaIntracranial Hemangiopericytoma+2 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)WithdrawnNCT03109301
What this trial is testing

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Neoplasms, Nerve TissueNeurofibromatosis 1Heredodegenerative Disorders, Nervous System+1 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03672838
What this trial is testing

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Who this might be right for
Neurofibromatosis 1 and 2 (NF1 and NF2)
NYU Langone Health 33
Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14
Next Page